PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22617001-3	2012	Polydopamine was deposited on the surface of biocompatible poly(L-lactide-co-epsilon-caprolactone) (PLCL) elastomer, on which vascular endothelial growth factor (VEGF) was subsequently immobilized by simple dipping.	polydopamine	0-12	vascular endothelial growth factor A	Homo sapiens	126-160	
22617001-3	2012	Polydopamine was deposited on the surface of biocompatible poly(L-lactide-co-epsilon-caprolactone) (PLCL) elastomer, on which vascular endothelial growth factor (VEGF) was subsequently immobilized by simple dipping.	polydopamine	0-12	vascular endothelial growth factor A	Homo sapiens	162-166	
22617001-5	2012	Immobilization of VEGF on the polydopamine-deposited PLCL films was effective (19.8 +- 0.4 and 197.4 +- 19.7 ng/cm(2) for DPv20 and DPv200 films, respectively), and biotin-mediated labeling of immobilized VEGF revealed that the fluorescence intensity increased as a function of the concentration of VEGF solution.	polydopamine	30-42	vascular endothelial growth factor A	Homo sapiens	18-22	
22617001-5	2012	Immobilization of VEGF on the polydopamine-deposited PLCL films was effective (19.8 +- 0.4 and 197.4 +- 19.7 ng/cm(2) for DPv20 and DPv200 films, respectively), and biotin-mediated labeling of immobilized VEGF revealed that the fluorescence intensity increased as a function of the concentration of VEGF solution.	polydopamine	30-42	vascular endothelial growth factor A	Homo sapiens	205-209	
22617001-5	2012	Immobilization of VEGF on the polydopamine-deposited PLCL films was effective (19.8 +- 0.4 and 197.4 +- 19.7 ng/cm(2) for DPv20 and DPv200 films, respectively), and biotin-mediated labeling of immobilized VEGF revealed that the fluorescence intensity increased as a function of the concentration of VEGF solution.	polydopamine	30-42	vascular endothelial growth factor A	Homo sapiens	205-209